During the past decade, DCT- Shah Research, LLC dba Discovery Clinical Trials conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DCT- Shah Research, LLC dba Discovery Clinical Trials" #1 sponsor was "Allergan" with 2 trials, followed by "Shire" with 2 trials sponsored, "TherapeuticsMD" with 2 trials sponsored, "Aerie Pharmaceuticals" with 1 trials sponsored and "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DCT- Shah Research, LLC dba Discovery Clinical Trials" #1 collaborator was "Allergan Sales, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "DCT- Shah Research, LLC dba Discovery Clinical Trials" are "Menopause" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Corneal Edema After Cataract Surgery" (1 trials) and "Dry Eye Disease (DED)" (1 trials). Many other conditions were trialed in "DCT- Shah Research, LLC dba Discovery Clinical Trials" in a lesser frequency.

Most popular intervention types in "DCT- Shah Research, LLC dba Discovery Clinical Trials" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Estradiol" (2 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials) and "011516X (New Artificial Tear Formulation)" (1 trials). Other intervention names were less common.

The vast majority of trials in "DCT- Shah Research, LLC dba Discovery Clinical Trials" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "DCT- Shah Research, LLC dba Discovery Clinical Trials". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in DCT- Shah Research, LLC dba Discovery Clinical Trials, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in DCT- Shah Research, LLC dba Discovery Clinical Trials, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".